JINXIN FERTILITY GROUP LIMITED Jinxin Fertility Group Limited Share Price
Equities
1951
KYG5140J1013
Healthcare Facilities & Services
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.6 HKD | +5.69% |
|
+14.54% | -22.39% |
| Sales 2023 | 2.79B 385M 3.01B 30.82B | Sales 2024 * | 3.21B 443M 3.47B 35.5B | Capitalization | 6.64B 916M 7.17B 73.35B |
|---|---|---|---|---|---|
| Net income 2023 | 345M 47.61M 373M 3.81B | Net income 2024 * | 441M 60.86M 476M 4.87B | EV / Sales 2023 | 2.97 x |
| Net cash position 2023 * | 137M 18.9M 148M 1.51B | Net Debt 2024 * | 1.16B 159M 1.25B 12.77B | EV / Sales 2024 * | 2.43 x |
| P/E ratio 2023 |
25.4
x | P/E ratio 2024 * |
14.8
x | Employees | 3,231 |
| Yield 2023 * |
1.46% | Yield 2024 * |
3.77% | Free-Float | 76.82% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
| 1 day | +5.69% | ||
| 1 week | +14.54% | ||
| Current month | +7.00% | ||
| 1 month | +10.64% | ||
| 3 months | +11.11% | ||
| 6 months | -30.48% | ||
| Current year | -22.39% |
1 week
2.27
2.61
1 month
2.242.61
Current year
2.053.40
1 year
2.055.23
3 years
2.0523.50
5 years
2.0524.55
10 years
2.0524.55
| Managers | Title | Age | Since |
|---|---|---|---|
Yang Dong
CEO | Chief Executive Officer | 37 | 02/05/18 |
Rong Lyu
CEO | Chief Executive Officer | 43 | 02/12/21 |
Yong Zhong
CHM | Chairman | 52 | 11/09/18 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Min Fang
BRD | Director/Board Member | 45 | 24/12/18 |
John Wilcox
BRD | Director/Board Member | 61 | 24/12/18 |
Yi Jiang Zhuang
BRD | Director/Board Member | 60 | 02/06/19 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.17% | 3 M€ | -0.84% | - | |
| 0.14% | 2 M€ | -14.14% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | 2.6 | +5.69% | 26,827,100 |
| 25/04/24 | 2.46 | -0.81% | 14,101,000 |
| 24/04/24 | 2.48 | +3.33% | 11,426,000 |
| 23/04/24 | 2.4 | +3.45% | 9,635,110 |
| 22/04/24 | 2.32 | +2.20% | 4,809,500 |
Delayed Quote Hong Kong S.E., April 26, 2024 at 09:08 am
More quotes
Jinxin Fertility Group Limited is a China-based company principally engaged in the provision of assisted reproductive services (ARS). The Company operates its business through three segments. The ARS segment primarily provides its patients with two treatment solutions: artificial insemination (AI) and in vitro fertilization (IVF) technology. The Management Services segment provides management services to Jinjiang IVF Center and Jinxin Fertility Center. The Ancillary Medical Services segment mainly provides medical services in the areas of gynecology, urology and internal medicine through Shenzhen Zhongshan Hospital. The Company mainly operates its business in China and the Unites.
Calendar
26/08/2024
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
BUY
Number of Analysts
19
Last Close Price
2.407
CNY
Average target price
4.184
CNY
Spread / Average Target
+73.85%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -22.39% | 916M | |
| -14.92% | 84.68B | |
| +13.30% | 81.12B | |
| +10.92% | 29.4B | |
| -12.71% | 16.73B | |
| -3.06% | 16.36B | |
| -2.63% | 14.92B | |
| -31.75% | 11.77B | |
| -1.42% | 11.72B | |
| +27.44% | 11.71B |
- Stock Market
- Equities
- 1951 Stock
